Logo image of ZCMD

ZHONGCHAO INC-CLASS A (ZCMD) Stock Fundamental Analysis

NASDAQ:ZCMD - Nasdaq - KYG9897X1152 - Common Stock - Currency: USD

1.39  -0.05 (-3.47%)

Fundamental Rating

3

Overall ZCMD gets a fundamental rating of 3 out of 10. We evaluated ZCMD against 71 industry peers in the Diversified Consumer Services industry. No worries on liquidiy or solvency for ZCMD as it has an excellent financial health rating, but there are worries on the profitability. ZCMD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ZCMD had negative earnings in the past year.
In the past year ZCMD had a positive cash flow from operations.
In multiple years ZCMD reported negative net income over the last 5 years.
In multiple years ZCMD reported negative operating cash flow during the last 5 years.
ZCMD Yearly Net Income VS EBIT VS OCF VS FCFZCMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

ZCMD's Return On Assets of -27.15% is on the low side compared to the rest of the industry. ZCMD is outperformed by 75.00% of its industry peers.
ZCMD has a worse Return On Equity (-36.93%) than 62.50% of its industry peers.
Industry RankSector Rank
ROA -27.15%
ROE -36.93%
ROIC N/A
ROA(3y)-17.79%
ROA(5y)-3.55%
ROE(3y)-24.02%
ROE(5y)-6.35%
ROIC(3y)N/A
ROIC(5y)N/A
ZCMD Yearly ROA, ROE, ROICZCMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

With a Gross Margin value of 51.28%, ZCMD perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
ZCMD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ZCMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.77%
GM growth 5Y-7.7%
ZCMD Yearly Profit, Operating, Gross MarginsZCMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

8

2. Health

2.1 Basic Checks

ZCMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZCMD has less shares outstanding than it did 1 year ago.
ZCMD has less shares outstanding than it did 5 years ago.
ZCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ZCMD Yearly Shares OutstandingZCMD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ZCMD Yearly Total Debt VS Total AssetsZCMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

ZCMD has an Altman-Z score of 1.69. This is a bad value and indicates that ZCMD is not financially healthy and even has some risk of bankruptcy.
ZCMD has a better Altman-Z score (1.69) than 65.63% of its industry peers.
ZCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.69
ROIC/WACCN/A
WACC9.03%
ZCMD Yearly LT Debt VS Equity VS FCFZCMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 6.05 indicates that ZCMD has no problem at all paying its short term obligations.
The Current ratio of ZCMD (6.05) is better than 93.75% of its industry peers.
ZCMD has a Quick Ratio of 5.94. This indicates that ZCMD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 5.94, ZCMD belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.05
Quick Ratio 5.94
ZCMD Yearly Current Assets VS Current LiabilitesZCMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

ZCMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.91%, which is quite good.
Looking at the last year, ZCMD shows a small growth in Revenue. The Revenue has grown by 1.01% in the last year.
Measured over the past years, ZCMD shows a quite strong growth in Revenue. The Revenue has been growing by 8.60% on average per year.
EPS 1Y (TTM)15.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.89%
Revenue 1Y (TTM)1.01%
Revenue growth 3Y2.61%
Revenue growth 5Y8.6%
Sales Q2Q%-19.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZCMD Yearly Revenue VS EstimatesZCMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ZCMD Yearly EPS VS EstimatesZCMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZCMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZCMD Price Earnings VS Forward Price EarningsZCMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZCMD Per share dataZCMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZCMD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZHONGCHAO INC-CLASS A

NASDAQ:ZCMD (2/21/2025, 8:00:02 PM)

1.39

-0.05 (-3.47%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-04 2022-10-04/dmh
Earnings (Next)12-13 2022-12-13/dmh
Inst Owners0.52%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap7.80M
Analysts0
Price TargetN/A
Short Float %0.08%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF 2.87
P/B 0.44
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-2.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.48
OCFY34.84%
SpS3.1
BVpS3.15
TBVpS3.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.15%
ROE -36.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.28%
FCFM N/A
ROA(3y)-17.79%
ROA(5y)-3.55%
ROE(3y)-24.02%
ROE(5y)-6.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.77%
GM growth 5Y-7.7%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 868.13%
Cap/Sales 16.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.05
Quick Ratio 5.94
Altman-Z 1.69
F-Score5
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)370.14%
Cap/Depr(5y)493.14%
Cap/Sales(3y)8.93%
Cap/Sales(5y)7.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.01%
Revenue growth 3Y2.61%
Revenue growth 5Y8.6%
Sales Q2Q%-19.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y88.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-142.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y502.04%
OCF growth 3YN/A
OCF growth 5Y-47.14%